吉林治疗包皮好医院(吉林包皮有裂口是怎么回事) (今日更新中)

WASHINGTON, Aug. 12 (Xinhua) -- NASA announced Friday the creation of a new directorate that will focus on both the International Space Station operations and human exploration beyond low earth orbit.The Human Exploration and Operations Mission Directorate combines the Space Operations and Exploration Systems mission directorates. While the transition and personnel assignments will take several weeks to finalize, the directorate already is supporting space station operations. It also will manage commercial crew and cargo developmental programs; construction of the Orion Multipurpose Crew Vehicle, a spacecraft designed to travel beyond low Earth orbit; development of a new heavy lift rocket, known as the Space Launch System; and other programs within the directorates."America is opening a bold new chapter in human space exploration," NASA Administrator Charles Bolden said in a statement. "By combining the resources of Space Operations and Exploration Systems, and creating the Human Exploration and Operations Mission Directorate, we are recommitting ourselves to American leadership in space for years to come."Associate Administrator Bill Gerstenmaier will head the new organization. He previously served as the associate administrator for Space Operations.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

COPENHAGEN, May 30 (Xinhua) -- The number of confirmed E. coli cases has risen to 14 in Denmark, with at least 26 others suspected of having the intestinal infection, the National Serum Institute said Monday.Seven of the confirmed cases show symptoms of kidney failure which marks an advanced stage of the sickness, the institute said."Almost all of the 14 infected people have been in northern Germany recently except just one. There is a 24-year-old man from Jutland. He has not even been to Germany, so he does not quite fit with the rest of the pattern," said Kaare Moelbak, chief physician at the institute. "We do not know yet how he has been so unlucky to get this infection but we assume that it has been a person-to-person transmission, or that he has eaten infected vegetables," he added.Denmark's Veterinary and Food Administration (DVFA) had advised Danish consumers not to eat raw tomato, lettuce and cucumber from Germany, and cucumber from Spain.It is now checking Danish cucumbers for traces of E. coli, with results expected on Tuesday.

WASHINGTON, June 7 (Xinhua) -- Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study published Tuesday in Gastroenterology, the official journal of the American Gastroenterological Association Institute.The study shows that patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non- drinkers.Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable serum at week 48; and 11 percent had a sustained virologic response. In contrast, the corresponding proportions for those who drank three or more cups of coffee per day were 73 percent, 52 percent, 49 percent and 26 percent, respectively."Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies."Approximately 70 to 80 percent of individuals exposed to HCV become chronically infected. Worldwide, these individuals are estimated to number between 130 and 170 million. Higher coffee consumption has been associated with slower progression of pre- existing liver disease and lower risk of liver cancer. However, the relationship with response to anti-HCV treatment had not been previously evaluated.

JIUQUAN, Gansu, Sept. 26 (Xinhua) -- Engineers are conducting the final preparations before launching China's first space laboratory module at the end of this week at a launch center in northwest China.The unmanned Tiangong-1 module was originally scheduled to be launched into low Earth orbit between Sept. 27 and 30. However, a weather forecast showing the arrival of a cold air mass at the Jiuquan Satellite Launch Center forced the launch to be rescheduled for Sept. 29 or 30, depending on weather and other factors."This is a significant test. We've never done such a thing before," said Lu Jinrong, the launch center's chief engineer.A full ground simulation was conducted on Sunday afternoon to ensure that the module and its Long March 2F carrier rocket are prepared for the actual launch.Cui Jijun, commander-in-chief of the launch site system and director of Jiuquan Satellite Launch Center, told Xinhua that they developed a new target spacecraft for the mission and made more than 170 technical improvements to the Long March 2F, China's manned orbital carrier rocket.Engineers have also made more than 100 updates at the launch site in order to make it compatible with the Tiangong-1, Cui added.The module will conduct docking experiments after entering orbit, which is the first step in China's space station program.Cui said the launch site has an updated computer center and command monitoring system and increased ability to adapt to changes in mission conditions, as well as the resources to handle both the launch and command duties. An integrated simulation training system for space launching has also been developed for the docking mission.The mission comes just one month after the Long March 2C rocket malfunctioned and failed to send an experimental satellite into orbit. The Tiangong-1 mission was subsequently rescheduled in order to allow engineers to sort out any problems that might occur during the launch.Cui said that engineers conducted a two-month comprehensive technical check on equipment at the launch site from March to May. The safety and reliability of all the instruments have been significantly improved."[The launch site] has the full conditions to conduct the Tiangong-1 mission," said Cui.The Tiangong-1 will remain in orbit for two years. During its mission, it will dock with China's Shenzhou-8, -9 and -10 spacecrafts.Unmanned docking procedures will be an essential step toward China achieving its goal of establishing a manned space station around 2020.

来源：资阳报